Joe Shindoh

872 total citations
22 papers, 306 citations indexed

About

Joe Shindoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Joe Shindoh has authored 22 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Joe Shindoh's work include Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (6 papers). Joe Shindoh is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (6 papers). Joe Shindoh collaborates with scholars based in Japan, Switzerland and Australia. Joe Shindoh's co-authors include Fumihiro Asano, Takashi Ishida, Satoshi Morita, Naofumi Shinagawa, Akifumi Tsuzuku, Satoshi Oizumi, Masaki Anzai, Takashi Abe, Ryujiro Suzuki and Yoshinori Hasegawa and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Joe Shindoh

19 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joe Shindoh Japan	8	243	47	24	23	22	22	306
Hee‐Jung Ban South Korea	10	230 0.9×	109 2.3×	31 1.3×	18 0.8×	48 2.2×	25	338
Takanori Kawabata Japan	10	122 0.5×	140 3.0×	56 2.3×	44 1.9×	18 0.8×	29	273
Susana Padrones Spain	9	143 0.6×	54 1.1×	22 0.9×	28 1.2×	25 1.1×	21	298
A Jones United States	9	151 0.6×	31 0.7×	125 5.2×	55 2.4×	54 2.5×	16	402
Patricia Banks Australia	9	123 0.5×	118 2.5×	61 2.5×	12 0.5×	32 1.5×	14	255
Franco Fabio Stellari Italy	11	250 1.0×	33 0.7×	28 1.2×	23 1.0×	36 1.6×	31	346
L. F. Putney United States	6	135 0.6×	16 0.3×	7 0.3×	22 1.0×	23 1.0×	6	355
Yasuharu Nakahara Japan	11	151 0.6×	58 1.2×	9 0.4×	40 1.7×	15 0.7×	47	284
Giampaolo Montesi Italy	9	39 0.2×	51 1.1×	30 1.3×	48 2.1×	32 1.5×	34	208
Magali N. Taylor United Kingdom	7	92 0.4×	13 0.3×	23 1.0×	17 0.7×	11 0.5×	11	136

Countries citing papers authored by Joe Shindoh

Since Specialization

Citations

This map shows the geographic impact of Joe Shindoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe Shindoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe Shindoh more than expected).

Fields of papers citing papers by Joe Shindoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe Shindoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe Shindoh. The network helps show where Joe Shindoh may publish in the future.

Co-authorship network of co-authors of Joe Shindoh

This figure shows the co-authorship network connecting the top 25 collaborators of Joe Shindoh. A scholar is included among the top collaborators of Joe Shindoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe Shindoh. Joe Shindoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsuoka, Tomoko, Yasuyuki Fukami, Joe Shindoh, et al.. (2018). Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention. International Journal of Clinical Practice. 72(3). e13065–e13065. 21 indexed citations

Katô, Toshio, Masahiro Morise, Masahiko Ando, et al.. (2016). Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?. Journal of Cancer Research and Clinical Oncology. 142(7). 1629–1640. 3 indexed citations

Takahashi, Kosuke, Hiroshi Saito, Yoshinori Hasegawa, et al.. (2014). First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 0901. Cancer Chemotherapy and Pharmacology. 74(4). 721–727. 27 indexed citations

Morise, Masahiro, Hiroyuki Taniguchi, Hideo Saka, et al.. (2014). Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System. Molecular and Clinical Oncology. 2(6). 991–996. 7 indexed citations

Saito, Hiroshi, Kosuke Takahashi, Hideo Saka, et al.. (2014). Cefepime monotherapy for febrile neutropenia in patients with lung cancer. Journal of Infection and Chemotherapy. 20(6). 365–369. 3 indexed citations

Kimura, Tomoki, Hiroyuki Taniguchi, Tomohiko Ogasawara, et al.. (2014). Phase || Study of Pemetrexed + Carboplatin + Bevacizumab As First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer with Egfr Mutation, Result of Induction Therapy: Central Japan Lung Study Group (Cjlsg) 0910 Trial. Annals of Oncology. 25. iv454–iv454.

Asano, Fumihiro, Naofumi Shinagawa, Takashi Ishida, et al.. (2013). Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy. A Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 188(3). 327–333. 128 indexed citations

Shindo, Yuichiro, Ryota Ito, Daisuke Kobayashi, et al.. (2012). Risk Factors of Resistant Pathogens for β-Lactam Plus Macrolide, or Fluoroquinolone in Patients With CAP and HCAP: A Multicenter Prospective Observational Study Among Hospitalized Patients With CAP, HCAP, and HAP in Japan (CJLSG 0911). CHEST Journal. 142(4). 150A–150A.

Matsuno, Yoshihiko, Fumihiro Asano, Joe Shindoh, et al.. (2011). CT-guided Ultrathin Bronchoscopy: Bioptic Approach and Factors in Predicting Diagnosis. Internal Medicine. 50(19). 2143–2148. 16 indexed citations

10.

Ichikawa, Motoshi, Ryujiro Suzuki, Kensuke Kataoka, et al.. (2010). Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: A multi-center phase II study. Lung Cancer. 69(3). 319–322. 6 indexed citations

11.

Takahashi, Kosuke, Hiroshi Saito, Yukihiro Hasegawa, et al.. (2009). 9142 A phase II study of gefitinib monotherapy as first-line treatment for elderly patients with stage IIIB/IV adenocarcinoma of the lung. European Journal of Cancer Supplements. 7(2). 547–547. 1 indexed citations

12.

Suzuki, Ryujiro, Masashi Yamamoto, Hideo Saka, et al.. (2008). A phase II study of carboplatin and paclitacel with meloxicam. Lung Cancer. 63(1). 72–76. 17 indexed citations

13.

Kataoka, Kensuke, Ryujiro Suzuki, Hiroyuki Taniguchi, et al.. (2006). Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer. Lung. 184(3). 133–139. 5 indexed citations

14.

Asano, Fumihiro, et al.. (2004). Ultrathin Bronchoscopic Barium Marking With Virtual Bronchoscopic Navigation for Fluoroscopy-Assisted Thoracoscopic Surgery. CHEST Journal. 126(5). 1687–1693. 38 indexed citations

15.

Suzuki, Ritsuro, Hirokazu Taniguchi, Joe Shindoh, et al.. (2004). A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7174–7174. 1 indexed citations

16.

Kimura, Tomoki, et al.. (2002). [Early image of squamous cell carcinoma in the peripheral lung field on high-resolution CT scan].. PubMed. 40(11). 884–8. 6 indexed citations

17.

Itoh, Y., et al.. (1993). [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi].. PubMed. 42(11). 1670–6. 2 indexed citations

18.

Shindoh, Joe, Satoru Sugiyama, Kenzo Takagi, Tatsuo Satake, & Takayuki Ozawa. (1991). Recovery Time Course of Airway Hyperresponsiveness to Acetylcholine After Ovalbumin Challenge in Guinea Pigs. CHEST Journal. 99(5). 1274–1279. 8 indexed citations

19.

Nakashima, Yasuhiro, et al.. (1990). Effects of sodium channel blockers on electrical field stimulation-induced guinea-pig tracheal smooth muscle contraction.. PubMed. 306. 130–8. 5 indexed citations

20.

Shindoh, Joe, et al.. (1990). TIME COURSE OF RECOVERY OF β‐ AND α₁‐ADRENOCEPTORS IN EXPERIMENTAL ASTHMA. Clinical and Experimental Pharmacology and Physiology. 17(7). 485–494. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact